supported by grants from National Natural Science Foundation of China(81973366,81773782,81903695 and 82003792);CAMS Innovation Fund for Medical Sciences(2016I2M-1-011,China);National Mega-project for Innovative Drugs(2019ZX09721-001,China);Chinese Pharmaceutical Association-Yiling Pharmaceutical Innovation Fund for Biomedicine(GL-1-B04-20180366,China)。
Programmed cell death ligand 1(PD-L1)/programmed cell death protein 1(PD-1)cascade is an effective therapeutic target for immune checkpoint blockade(ICB)therapy.Targeting PD-L1/PD-1 axis by small-molecule drug is an a...
grants from the National Natural Science Foundation of China (Nos. 81422051, 81472593, and 31401208);the Hunan Natural Science Foundation of China (No. 2016JJ1020).
Autophagy, a form of cellular self-digestion by lysosome, is associated with various disease processes including cancers, and modulating autophagy has shown promise in the treatment of various malignancies. A number o...
Aim: Tubeimoside-1 (TBMS1), a triterpenoid saponin extracted from the Chinese herbal medicine Bolbostemma paniculatum (Maxim) Franquet (Cucurbitaceae), has shown anticancer activities in various cancer cell lin...
The structure of tubeimoside V (1), a new cyclic bisdesmoside, isolated from tubers of Bolbostemma paniculatum (Tu Bei Mu), was established by means of 2D NMR spectral and chemical methods. Compound 1 has inter-saccha...
The research work was partly carried out in the Department of Biochemistry Kyoto Prefectural University of Medicine Japan
Numerous attempts have been made to select compounds that might reduce the incidence of cancer. Previously we have found out that several kinds of natural and